Sphere Medical Holding PLC (LON:SPHR) was the biggest faller in London on Tuesday after it unveiled plans to cancel its AIM listing as it looks to facilitate a much-needed £8mln investment led by Neil Woodford. The company, which makes the Proxima blood gases monitors, said the investment was conditional on it de-listing and becoming a privately-held entity.
Specialist recruiter Empresaria Group plc (LON:EMR) has confirmed to investors that it enjoyed a record first half performance, boosted by strong performances from its recent acquisitions. As flagged in last month’s trading update, net fee income – gross profit – for the six months ended 30 June jumped 26% to £34.4mln (H1 2016: £27.2mln) on significantly higher revenues of £173.4mln (H1 2016: £106.1mln).
Drug developer Sareum Holdings Plc (LON:SAR) expects profit and cash at bank to be ahead of market expectations when it reports its results for the 12 months ended 30 June 2017 later this year.
Haydale Graphene Industries PLC (LON:HAYD), the global advanced materials group that has developed functional uses for the new wonder material graphene, has signed an outline commercial collaboration deal with Rogers Advanced Composites (RAC). Haydale chief executive Ray Gibbs said the pair had spent over two years in mixing, dispersing and processing of a range of nanomaterials into high-end epoxy resins.
OptiBiotix Health plc (LON:OPTI) has announced an expansion of a key manufacturing and supply agreement. It is broadening its European tie-up with Italian food company Sacco, signed in March, to cover the US and rest of the world.
BOS GLOBAL Holdings Limited (LON:BOS) managing director Michael Travia restated his view that the developer of workplace productivity software is at a “tipping point” in its development. The comment was made as the company announced two significant deals for its BOS Time enterprise product.
Rose Petroleum PLC (LON:ROSE) has now secured all necessary permits and permissions for its planned 3D seismic exploration programme in Utah’s Paradox basin, onshore United States. The permitting process for the proposed survey is now complete, the company said in a statement.
Sound Energy PLC (LON:SOU) has told investors that has nearly wrapped up its operations at the Badile exploration project in Italy. The company said that the drilling rig has now been fully disassembled and that operations to plug and abandon the well – including the restoration of the site – is expected to be complete by the end of September.
Kibo Mining Limited (LON:KIBO) has submitted an updated version of its MOU for the development of the Mbeya coal and power project to the relevant Tanzanian ministry. Meanwhile, funding talks continue to progress.
Premier African Minerals Limited (LON:PREM) has provided details of a new drilling programme being undertaken by Casa Mining in the Democratic Republic of Congo. Ortac has a 22.2% stake and Premier African Minerals has a 4.5% stake in Casa Mining.
Bushveld Minerals Limited (LON:BMN) has retired a US$3mln prepayment facility related to its acquisition in joint venture of Vametco, a South African vanadium company. Simultaneously, a US$3mln extension for a working capital facility for Vametco has been put in place.
Nostra Terra Oil and Gas Company plc (LON:NTOG) shares advanced on Tuesday Morning after it updated investors on a legal process in the United States that could see it either collect cash or take full ownership of the Pine Mills project. The AIM-quoted oiler currently owns an 87.5% interest in the Pine Mills project, which came with a pre-existing legal matter that is now drawing to a close.
e-therapeutics PLC (LON:ETX) revealed that both its non-executive chairman and chief executive officer had today increased their shareholdings in the firm following market purchases. The computer-based drug discovery platform company said chairman Ian Ross had purchased 250,000 shares, to take his total holding to 1.25mln shares, or 0.47% of the company, while CEO Ray Barlow acquired 270,000 shares to take his holding to 1.1mln shares, a 0.41% holding. The firm said both share purchases were made at a price of 10.6p per share. E-therapeutics shares were steady at 10.62p.
Greatland Gold plc (LON:GGP) said its chief executive officer Gervaise Heddle today acquired a further 750,000 of the company’s ordinary shares at a price of 0.545p each. Following the purchase, Heddle is beneficially interested in 3,750,000 ordinary Shares, representing 0.18% of Greatland’s issued share capital. Greatland shares were trading at 0.56p a share in late afternoon trading, down 2.6%.
Sam Catalano, Capital Network's mining analyst talks investors through European Metals Holdings (LON:EMH , ASX:EMH) key assets as well as strategy and outlook in a video today.